Umar TP, Ramadhan MS, Mahfuza N. Urokinase Plasminogen Activator Receptor (uPAR) Targeted Therapy with Switchable Chimeric Antigen Receptor T-Cell (sCAR T-Cell) Potential as Pancreatic Cancer Immunotherapy Agent. Int. J. Hum. Health Sci. [Internet]. 2020 Oct. 4 [cited 2025 Nov. 17];5(2):171-6. Available from: https://www.ijhhsfimaweb.info/IJHHS/article/view/255